Product Images Cyklokapron

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Cyklokapron NDC 0013-1114 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - cyklokapron 01

Chemical Structure - cyklokapron 01

Logo - cyklokapron 02

Logo - cyklokapron 02

This is a product promotion for "Injectables" by Plizer Labs, which is a division of Pfizer Inc, located in New York.*

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Label - cyklokapron 03

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Label - cyklokapron 03

This is a description of an injectable drug called "Cyklokapron" which contains 1000mg of tranexamic acid per 10ml ampule. The drug is indicated for intravenous use only and should be administered via a single-dose ampule. The unused portion of the drug should be discarded. The drug is manufactured by Piizer Labs and the National Drug Code (NDC) is 0013-1114-01. This product is distributed in New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Carton - NDC 0013-1114-01 - cyklokapron 04

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Carton - NDC 0013-1114-01 - cyklokapron 04

This is a medication called Cyklokapron also known as Tranexamic acid. It comes in a single-dose ampule of 10 mL containing 1000 mg/10 mL (100 mg/mL) of the solution for intravenous injection. The medication should be discarded after a single use and stored at a temperature between 15°C-30°C (50°F-86°F). The medication comes with prescription information which specifies the dosage and use. The ampule is manufactured in Japan and distributed by Phamacia & Upjohn Co, a division of Pfizer, Inc in New York City.*

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Carton - NDC 0013-1114-15 - cyklokapron 05

PRINCIPAL DISPLAY PANEL - 10 mL Ampule Carton - NDC 0013-1114-15 - cyklokapron 05

Cyklokapron® is a tranexamic acid injection for intravenous use. It comes in a 10mL single-dose ampule containing 1,000mg/10mL (100mg/mL) of tranexamic acid. The product should be stored at room temperature (15°-30°C / 59°-86°F) and should be discarded if not used entirely. Made in Japan and distributed by Pfizer Labs. Dosage and use should be consulted with the accompanying documentation. Lot/exp/sn information is provided.*

PRINCIPAL DISPLAY PANEL - 10 x 10 mL Ampule Box Label - cyklokapron 06

PRINCIPAL DISPLAY PANEL - 10 x 10 mL Ampule Box Label - cyklokapron 06

Cyklokapron is a solution for intravenous injection used as a single dose containing 1000 mg/10 mL (100 mg/mL) of tranexamic acid. Each ampule contains 1 g tranexamic acid. It is distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY. The drug should be stored at 25°C (77°F), and excursions to 15°-30°C (50°-86°F) are permitted. The product is for Rx only and the prescribing information should be read before use. The text also includes NDC and PAA number as well as manufacturing information.*

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - cyklokapron 07

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label - cyklokapron 07

Cyklokapron® is an injection medication containing tranexamic acid used for intravenous use only. It comes in a single-dose vial and contains 1,000 mg of tranexamic acid per 10 mL of solution (100 mg/mL). The product should be discarded if any portion remains unused. The medication is distributed by Pfizer Labs, a division of Pfizer Inc. located in New York, NY 10017.*

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box - cyklokapron 08

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box - cyklokapron 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.